Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives
Open Access
- 18 May 2020
- journal article
- Published by Peertechz Publications Private Limited in Archives of Clinical Gastroenterology
- Vol. 6 (2), 031-035
- https://doi.org/10.17352/2455-2283.000075
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Intestinal microbiota in functional bowel disorders: a Rome foundation reportGut, 2012
- Clinical trial:Lactobacillus plantarum299v (DSM 9843) improves symptoms of irritable bowel syndromeWorld Journal of Gastroenterology, 2012
- Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind studyWorld Journal of Gastroenterology, 2012
- Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2010
- Therapeutic Effect of Lactobacillus acidophilus-SDC 2012, 2013 in Patients with Irritable Bowel SyndromeDigestive Diseases and Sciences, 2008
- Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in miceInternational Journal of Food Microbiology, 2007
- Design of Treatment Trials for Functional Gastrointestinal DisordersGastroenterology, 2006
- The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome—a double blind, placebo-controlled, randomized studyClinical Nutrition, 2005
- The placebo effect in irritable bowel syndrome trials: a meta‐analysis1Neurogastroenterology & Motility, 2005
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997